SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending amidst strong revenue performance, an influx of new strategic partnerships with global mobile operators, and multiple analyst price target upgrades. The community is actively celebrating this commercial validation and robust financial runway, anticipating a short squeeze and continued upward momentum for its direct-to-device satellite network.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is surging as investors eagerly await imminent Phase 3 REGAL trial results for its AML therapy, GPS, anticipating groundbreaking success that could trigger a significant short squeeze or major pharma buyout. The community believes extended trial duration and previous data signal strong patient outcomes, positioning the stock for a major repricing.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending as investors grapple with uncertainty over its release from government conservatorship, fueled by recent directives for substantial mortgage bond purchases that suggest continued federal control over privatization. Community discussion highlights frustration over perceived delays and potential share dilution, while long-term holders maintain optimism due to the company's consistent profitability.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is making waves with its transformative acquisition of Covelya Group, a deal poised to establish it as a dominant force in subsea technology and integrated underwater autonomy solutions. The community is actively debating the short-term impact of share dilution versus the substantial long-term growth and strategic advantages this vertical integration brings, especially given rising defense spending.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power is trending following key regulatory clearances for its high-purity graphene in major global markets, alongside an operational production facility. The community is buzzing with enthusiasm over the company's unique material technology and strategic positioning to capture significant demand across diverse industries, eagerly anticipating upcoming commercial milestones.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is trending after reporting solid quarterly results that were overshadowed by a conservative fiscal year 2027 guidance, causing a significant stock dip. While bulls see the new $400 million share repurchase and AI-driven platform potential as strong buy signals, bears point to slowing growth and increased competition within the software sector.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending amidst community debate over competitor Roche's Fenebrutinib trial data, contrasting its safety concerns with Briumvi's strong long-term efficacy, recently reinforced by JAMA Neurology publication. The stock is also gaining visibility from a national MS awareness campaign with Christina Applegate, while investors await upcoming earnings and discuss the implications of rising short interest.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending after reporting a significant Q4 2025 EPS beat, strong revenue growth, and positive 2026 guidance, alongside promising R289 pipeline data. Despite these strong financial results and a perceived low valuation, the stock's puzzling market reaction is fueling community frustration, high short interest, and ongoing buyout speculation within the biotech sector.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin (BTC) is trending as it breaks out of consolidation and shows signs of a significant rebound, with community discussion highlighting record short leverage poised for an unwind and strong institutional support at key price levels.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending after its Airobotics subsidiary secured an initial $20 million government contract for AI-driven autonomous border defense, though the community expresses frustration over perceived market manipulation and heavy shorting preventing the stock from fully reflecting this news and broader sector tailwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Wealth-management stocks slid on Tuesday after tech platform Altruist introduced an AI-powered tax planning tool.</li><li>Wurster said the selloff left him “disappointed and surprised” because he believes that AI would strengthen advisers’ capabilities.</li><li>Schwab is well-positioned to benefit from AI due to its scale and extensive data, Wurster added.</li></ul>Charles Schwab (SCHW) CEO Rick Wurster pushed back against growing concerns that artificial intelligence could disrupt the wealth management industry, arguing instead that the technology will enhance adviser productivity.Wurster emphasized that AI should be viewed as a supportive tool rather than a replacement for human expertise, according to a Bloomberg interview on Wednesday. “With the power of AI, not only are we reaching those clients we have a relationship with, we are able to help a whole new group of clients,” Wurst said.His comments came after a selloff that dragged down shares of several wealth-management firms following the launch of Altruist’s AI-powered tax planning tool on Tuesday.<a href="https://stocktwits.com/symbol/SCHW">SCHW stock</a> was down 3% in morning trade after closing over 7% lower in the previous session.<h2 class="st-heading-2">Altruist’s AI Tool Leads To Selloff</h2>Wealth-management stocks slid on Tuesday after tech platform Altruist introduced an AI-powered tax planning tool within its Hazel platform, raising concerns about pressure on traditional advisory services. Shares of Raymond James Financial fell over 8%, while Stifel Financial declined around 4% on Tuesday.The tool analyzes client financial data to create personalized tax strategies, aiming to improve outcomes and efficiency. Altruist added that strict zero data-retention agreements ensure customer information is not stored or used to train AI models.<h2 class="st-heading-2">Wurster Says He Is Disappointed And Surprised By Recent Selloff</h2>Wurster said the decline in the brokerage’s shares left him “disappointed and surprised” because he believes that artificial intelligence would strengthen advisers’ capabilities rather than replace them.“The market is missing that we are a natural winner in the AI space because of all of the advantages we have — because of our size, our scale, our data,” he said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment shifted to ‘bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/SCHW_jpg_af0628c78b.webp" alt="SCHW.jpg">However, some users expressed concerns about the company’s future amid the “AI onslaught”.<stembedurl>https://stocktwits.com/Free43ver/message/644650446</stembedurl><stembedurl>https://stocktwits.com/Mahaperrotta/message/644618898</stembedurl>SCHW stock has shed over 3% so far in 2026.was up 1.6% in pre-market trading after closing over 7% lower in the previous session.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/khc-stock-slumps-weak-q4-results-pauses-separation/cZb6X4CR4qY">Kraft Heinz Pauses Separation Plan Amid Weak Q4 Print – KHC Stock Slumps 7% Pre-Market</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Charles Schwab company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Charles Schwab CEO Reportedly Explains Why AI Won’t Disrupt Wealth Management Industry: ‘We Are Able To Help A Whole New Group Of Clients’

CEO Rick Wurster said that AI should be viewed as a supportive tool rather than a replacement for human expertise, according to an interview with Bloomberg on Wednesday.

Equity

<ul class="summary-bullets"><li>TD Cowen raised the price target on Charles Schwab to $135 from $134 while maintaining a ‘Buy’ rating on the shares.</li><li>Piper Sandler also raised the firm's price target to $105 from $100 while maintaining a ‘Neutral’ rating.&nbsp;</li><li>The financial services firm is expected to announce its fourth quarter results on Jan. 21.</li></ul>Financial services firm Charles Schwab Corp. (SCHW) is garnering retail attention after it received a series of price target updates from Wall Street analysts ahead of its quarterly results expected on Jan. 21.On Wednesday, TD Cowen raised the price target on Charles Schwab to $135 from $134 while maintaining a ‘Buy’ rating on the shares, according to TheFly. Piper Sandler also raised the firm's price target to $105 from $100 while maintaining a ‘Neutral’ rating.Earlier this week, Citizens raised its price target on Charles Schwab to $120 from $110 with an ‘Outperform’ rating, as per TheFly.Shares of SCHW climbed around 1.4% at the time of writing.<h2 class="st-heading-2">Analyst Rationale</h2>TD Cowen cited its bullish stance on traditional asset managers, albeit with a tighter focus on higher-conviction ideas, while maintaining exposure to alternatives with a shift toward more "Higher for Longer" positioning and less 2026 beta, in a note.Meanwhile, Citizens said its upgrade comes as it expects "positive" results and "reasonable" guidance in the fourth-quarter (Q4) 2025 results update, adding that the guidance framework often comes in conservatively as the drivers that can support the upside are mostly likely not factored into the company's framing.The brokerage firm’s Q4 earnings are expected later this month. According to data from Fiscal.ai, analysts expect the company to report $6.3 billion in revenues for the quarter, about 19% higher than the $5.3 billion in revenues reported from the same period last year. Meanwhile, street consensus on adjusted earnings per share (EPS) are estimated at $1.39, up from $1.01 reported in Q4 2024.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/SCHW">SCHW shares</a> jumped to ‘neutral’ from ‘bearish’ territory over the past 24 hours amid ‘high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_15_at_9_52_55_PM_png_e2c2dea2dc.webp" alt="Retail sentiment jumped to ‘neutral’ over the past 24 hours amid ‘high’ message volumes." width="1287" height="165"></figure>&nbsp;SCHW stock has gained over 40% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Close-up of sign with logo at Charles Schwab financial adviser branch in Pleasanton, California, March 26, 2018. (Photo by Smith Collection/Gado/Getty Images)

SCHW Stock Gets Multiple Wall Street Price Target Updates — What’s Driving The Optimism?

TD Cowen cited its bullish stance on traditional asset managers, while Citizens said its upgrade comes amid positive results and reasonable guidance expectations.

Why Did Charles Schwab Get A Series Of Price Target Updates?

ETFs to Keep Your Portfolio on Track in the Long Term

Despite November's volatility, optimism is returning to Wall Street. Discover how long-term strategies combined with ETFs can help investors build resilient portfolios ready to capture the next phase of the bull market.

Buy, Hold and Build Wealth: ETFs for Long-Term Investors

Market volatility is rising but buy-and-hold ETFs like SPY, VOO and VTI offer investors diversification and long-term resilience.

Current Price	$26.43
Prev Close	$26.25
Open	$26.34
Dividend Yield	N/A
50-Day Moving Average	$26.55
Beta	N/A
Avg. Volume	10.19M
PE Ratio	N/A

52-Week High	$26.94
52-Week Low	$18.53
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

SCHB
Schwab Strategic Trust - Schwab U.S. Broad Market ETF

Feed

News

Sentiment

Fundamentals

Info

Latest SCHB News

SCHBSchwab Strategic Trust - Schwab U.S. Broad Market ETF